Polymorph of (R) -3- (2-hydroxy-2, 2-diphenyl-acetoxy) -1- (isoxazol-s-ylcarbamoyl-methyl) - 1-azoni a-bicyclo- [2.2.2] octane bromide

Details for Australian Patent Application No. 2007291515 (hide)

Owner Novartis AG

Inventors Monnier, Stephanie; Muhrer, Gerhard

Agent Davies Collison Cave

Pub. Number AU-A-2007291515

PCT Pub. Number WO2008/025541

Priority 06119883.4 31.08.06 EP

Filing date 29 August 2007

Wipo publication date 6 March 2008

International Classifications

C07D 453/02 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

Event Publications

26 February 2009 PCT application entered the National Phase

  PCT publication WO2008/025541 Priority application(s): WO2008/025541

3 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007291517-Pharmaceutical compositions for the treatment of fungal infections

2007291514-Heterocyclic FXR binding compounds